Investments - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Schedule of Investments | |||
| Investments at fair value, cost basis | $ 220,422 | $ 172,640 | |
| Dividends received | 3,356 | 1,942 | $ 2,848 |
| Gain from sale of equity method investment | 20,714 | ||
| Investment gains on share issuances | 9,917 | ||
| Corporate Joint Venture | |||
| Schedule of Investments | |||
| Dividends received | 3,356 | 1,942 | $ 2,848 |
| Equity method investments | 43,825 | 38,143 | |
| Common Stock | |||
| Schedule of Investments | |||
| Unrealized gains (losses) on equity securities | $ (2,788) | 0 | |
| Common Stock shares sold | 6.0 | 20.5 | |
| Gain from sale of equity method investment | $ 20,174 | $ 20,714 | |
| Atlas Crest Sponsors | |||
| Schedule of Investments | |||
| Investments at fair value, cost basis | $ 1,895 | $ 887 | |
| X | ||||||||||
- Definition Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cost of the investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|